WASF3 and breast cancer: Our main hypothesis was that, since WAVE3 expression levels are very low in the normal PBMCs, any quantitative increased levels of WAVE3 in the blood of BC patients must come from the CTCs that have escaped the primary tumors a were disseminated in the circulation.